跳至主要内容
临床试验/NCT02231736
NCT02231736Unknown不适用

Incidence of Chromosomal Damage in Type 2 Diabetes Patients

University of Vienna1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
130
试验地点
1
主要终点
The quality of HbA1c influences micronuclei formation in binucleated cells

研究概览

简要总结

The purpose of the study is to determine whether glycemic control (HbA1c) is linked to chromosomal damage in type 2 Diabetes patients

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Type 2 Diabetes (T2DM)
  • Sex: female
  • Age: > 30years
  • Medication: oral anti-diabetics and/or Insulin therapy
  • Constant nutritional behavior, constant physical activity, constant weight for the last 4 weeks
  • Non-smoking for at least 1 year

排除标准

  • Patients with type 1 DM
  • Age: < 30years
  • Pregnant or lactating women
  • Participation in another clinical trial
  • Change of medication in regard to metabolic parameters within the last 4 weeks
  • Significant cardiovascular damage with NYHA > III
  • Liver disease with three-times higher transaminase values
  • Chronic kidney disease with serum creatinine > 2 mg/dl
  • HIV positive
  • History of chronic alcohol abuse in the last two years
  • History of cancer, stroke, organ transplantation

结局指标

主要结局

The quality of HbA1c influences micronuclei formation in binucleated cells

时间窗: Baseline

In this cross-sectional study the micronuclei formation in binucleated lymphocytes (Number of micronuclei/1000 binucleated cells) is compared between a low (HbA1c\<7.5%) and a high (HbA1c\>7.5%) glycemic group

次要结局

  • Type 2 diabetes duration of the subjects influences chromosomal damage(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karl-Heinz Wagner

Director Research Platform Active Ageing

University of Vienna

研究点 (1)

Loading locations...

相似试验